PFF Insights

In a win for the pulmonary fibrosis community, the U.S. House of Representatives Appropriations Committee included language in a fiscal year 2021 Appropriations report highlighting the need for pulmonary fibrosis (PF) research.

We’ve seen a lot of optimism about the development of several SARS-CoV-2 vaccines and treatments. A path to end the pandemic is becoming more clear and collaborative research is moving at an exponential pace. Unfortunately, with the reopening of several states, this optimism was counter balanced by the catastrophic increase of more than 60,000 new cases each day in the United States. We can change the course of the pandemic, but only by working together.

The impact of SARS-CoV-2 and COVID-19 is still evident in virtually every aspect of our lives. Numerous studies, more than 35 as of early June, are underway to identify treatments or vaccines for COVID-19. Read on to learn how to navigate PF clinical trials during COVID-19.

For the past several months, we’ve all been living in the SARS-CoV-2 pandemic, or the coronavirus that causes COVID-19. This has dramatically affected our community. Read on to learn how you can stay safe during these times.